Data Science Techniques for COVID-19 in Intensive Care Units.

Sergio Muñoz Lezcano; Fernando Carlos López Hernández; Alberto Corbi Bellot

doi:10.9781/ijimai.2020.11.008

Authors

Sergio Muñoz Lezcano Universidad Internacional De La Rioja
Fernando Carlos López Hernández Universidad Internacional De La Rioja
Alberto Corbi Bellot Universidad Internacional De La Rioja

DOI:

https://doi.org/10.9781/ijimai.2020.11.008

Keywords:

Coronavirus COVID-19, Data Mining, Machine Learning, Image Processing, Biomarkers, X-ray

Abstract

Data scientists aim to provide techniques and tools to the clinicians to manage the new coronavirus disease. Nowadays, new emerging tools based on Artificial Intelligence (AI), Image Processing (IP) and Machine Learning (ML) are contributing to the improvement of healthcare and treatments of different diseases. This paper reviews the most recent research efforts and approaches related to these new data driven techniques and tools in combination with the exploitation of the already available COVID-19 datasets. The tools can assist clinicians and nurses in efficient decision making with complex and heavily heterogeneous data, even in hectic and overburdened Intensive Care Units (ICU) scenarios. The datasets and techniques underlying these tools can help finding a more correct diagnosis. The paper also describes how these innovative AI+IP+ML-based methods (e.g., conventional X-ray imaging, clinical laboratory data, respiratory monitoring and automatic adjustments, etc.) can assist in the process of easing both the care of infected patients in ICUs and Emergency Rooms and the discovery of new treatments (drugs).

Downloads

Download data is not yet available.

References

[1] World Health Organization. (2020). WHO statement regarding cluster of pneumonia cases in Wuhan, China. Beijing: WHO, 9.

[2] C. Anastassopoulou, L. Russo, A. Tsakris, C. Siettos. Data-based analysis, modelling and forecasting of the COVID-19 outbreak. PloS one, vol. 15, no. 3, pp. e0230405, 2020.

[3] A. Alimadadi, S. Aryal, I. Manandhar, P. B. Munroe, B. Joe, X. Cheng. Artificial Intelligence & Machine Learning to Fight COVID19. 2020.

[4] P. K. Sethy, S. K. Behera. Detection of coronavirus Disease (COVID-19) based on Deep Features, 2020.

[5] F.A. Murphy. Emerging zoonoses. Emerg Infect Dis. Vol. 4, no. 3, pp. 429‐435, 1998.

[6] M.A. Shereen, S. Khan, A. Kazmi, N. Bashir R. Siddique. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, 2020.

[7] G. Venkatesan, V. Balamurugan, P. N. Gandhale, R. K. Singh, V. Bhanuprakash. Viral zoonosis: a comprehensive review. Asian Journal of Animal and Veterinary Advances, vol. 5, no. 2, pp. 77-92, 2010.

[8] S. Wan, Y. Xiang, W. Fang, Y. Zheng, B. Li, Y. Hu, X. Huang. Clinical features and treatment of COVID‐19 patients in northeast Chongqing. Journal of medical virology. 2020.

[9] T. Klopfenstein, L. Toko, P. Royer, Q. Lepiller, V. Gendrin, S. Zayet Features of anosmia in COVID-19. Médecine et Maladies infectieuses, 2020.

[10] World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020 (No. WHO/2019-nCoV/clinical/2020.5). World Health Organization.

[11] L. A. Vaira, G. Salzano, G. Deiana, G. De Riu. Anosmia and ageusia: common findings in COVID‐19 patients. The Laryngoscope, 2020.

[12] Massachusetts General Hospital Treatment Guidance for Critically Ill Patients w/ COVID-19. https://bit.ly/mghcovid. Last accessed July 2020.

[13] H. A. Rothan, S. N Byrareddy. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity, 102433, 2020.

[14] R. Li, C. Rivers, Q. Tan, M. B. Murray, E. Toner, M. Lipsitch. Estimated Demand for US Hospital Inpatient and Intensive Care Unit Beds for Patients With COVID-19 Based on Comparisons With Wuhan and Guangzhou, China. JAMA network open, vol. 3, no. 5, pp. e208297-e208297, 2020.

[15] P. Gautret, J. C. Lagier, P. Parola, L. Meddeb, M. Mailhe, B. Doudier, S. Honoré. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. International journal of antimicrobial agents, 105949, 2020.

[16] B. Cao, Y. Wang, D. Wen, W. Liu, J. Wang, G. Fan, X. Li. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. New England Journal of Medicine, 2020

[17] M. Wang, R. Cao, L. Zhang, X. Yang, J. Liu, M. Xu, G. Xiao. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell research, vol. 30, no. 3, pp. 269-271, 2020.

[18] P. Simon. Too Big to Ignore: The Business Case for Big Data. (Vol. 72). John Wiley & Sons, 2013.

[19] G. Gutierrez. Artificial Intelligence in the Intensive Care Unit. Critical Care, vol. 24, article number 101, pp. 1-9, 2020.

[20] G. S. Randhawa, M. P. Soltysiak, H. El Roz, C. P. de Souza, K. A. Hill, L. Kari. Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study. Plos one, vol. 15, no. 4, pp. e023239, 2020.

[21] S. Wang, B. Kang, J. Ma, X. Zeng, M. Xiao, J. Guo, B Xu. A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19). MedRxiv, 2020.

[22] A. Narin, C. Kaya, Z. Pamuk. Automatic detection of coronavirus disease (COVID-19) using X-ray images and deep convolutional neural networks. arXiv preprint arXiv:2003.10849, 2020.

[23] F.A. Saiz, I. Barandiaran. COVID-19 Detection in Chest X-ray Images using a Deep Learning Approach. International Journal of Interactive Multimedia and Artificial Intelligence, vol 6. n. 12, pp. 11-15, 2020.

[24] F. Cabitza, G. Banfi. Machine learning in laboratory medicine: waiting for the flood? Clinical Chemistry and Laboratory Medicine (CCLM), vol. 56, no. 4, pp. 516-524, 2018.

[25] N. Ferguson, D. Laydon, G. Nedjati, N. Imai, K. Ainslie, M. Baguelin, A. Dighe. Impact of non-pharmaceutical interventions to reduce COVID19 mortality and healthcare demand, 2020.

[26] P. Richardson, I. Griffin, C. Tucker, D. Smith, O. Oechsle, A. Phelan, J. Stebbing. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet (London, England), vol. 395. No. 10223, pp. e30-e31, 2020.

[27] M. J. Tobin. Mechanical Ventilation. New England Journal of Medicine, vol. 330, no. 15, pp. 1056–1061, 1994.

[28] L. Blanch, B. Sales, J. Montanya, U. Lucangelo, O. Garcia-Esquirol, A. Villagra, G Murias. Validation of the Better Care system to detect ineffective efforts during expiration in mechanically ventilated patients: a pilot study. Intensive Care Medicine, vol. 38, no. 5, pp. 772–780, 2012.

[29] B. Gholami, T.S. Phan, W.M. Haddad, A. Cason, J. Mullis, L. Price, J.M. Bailey. Replicating human expertise of mechanical ventilation waveform analysis in detecting patient ventilator cycling asynchrony using machine learning, Computers in Biology and Medicine, 2018.

[30] M. T. Kwong, G. W. Colopy, A. M. Weber, A. Ercole, J. H. Bergmann. The efficacy and effectiveness of machine learning for weaning in mechanically ventilated patients at the intensive care unit: a systematic review. Bio-Design and Manufacturing, vol. 2, no. 1, pp. 31-40, 2019

[31] S. Salehi, A. Abedi, S. Balakrishnan, A. Gholamrezanezhad. Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients. American Journal of Roentgenology, pp. 1-7, 2020.

[32] Y. Oba, T. Zaza. Abandoning daily routine chest radiography in the intensive care unit: meta-analysis. Radiology, vol. 255, no. 2, pp. 386-395, 2010.

[33] X. Xu, X. Jiang, C. Ma, P. Du, X. Li, S. Lv, Y. Li. Deep learning system to screen coronavirus disease 2019 pneumonia. arXiv preprint, 2020.

[34] L. Wang, A. Wong. COVID-Net: A Tailored Deep Convolutional Neural Network Design for Detection of COVID-19 Cases from Chest X-Ray Images. arXiv preprint arXiv:2003.09871, 2020.

[35] J. Deng, W. Dong, R. Socher, L. Li, K. Li, L. Fei-Fei. Imagenet: A large-scale hierarchical image database. In 2009 IEEE conference on computer vision and pattern recognition, pages 248–255, 2009.

[36] J. P. Cohen, P. Morrison, L. Dao, K. Roth, T. Duong, M. Ghassemi. COVID-19 Image Data Collection: Prospective Predictions Are the Future. arXiv preprint, 2020.

[37] X. Wang, Y. Peng, L. Lu, Z. Lu, M. Bagheri, R. Summers. ChestX-ray8: Hospital-scale Chest X-ray Database and Benchmarks on Weakly Supervised Classification and Localization of Common Thorax Diseases. In Proceedings of the IEEE conference on computer vision and pattern recognition (pp. 2097-2106), 2020.

[38] Radiological Society of North America. RSNA pneumonia detection challenge. https://bit.ly/kagglersna. Last accessed July 3, 2020.

[39] V. M. Corman, O. Landt, M. Kaiser, R. Molenkamp, A. Meijer, D. K. Chu, D. G. Mulders. Detection of 2019 novel coronavirus (2019-nCoV) by realtime RT-PCR. Eurosurveillance, vol. 25, no. 3, pp. 2000045, 2020.

[40] Explained: how to identify active covid-19 infection in people. https:// www.researchamerica.org/blog/explained-how-identify-active-covid19-infection-people by 06/07/2020. Last accessed July 3, 2020.

[41] M. Arentz, E. Yim, L. Klaff. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. Published online March 19, 2020.

[42] L. Yan, H. T. Zhang, J. Goncalves, Y. Xiao, M. Wang, Y. Guo, X. Huan. A machine learning-based model for survival prediction in patients with severe COVID-19 infection. medRxiv, 2020.

[43] J. Wu, P. Zhang, L. Zhang, W. Meng, J. Li, C. Tong, M. Zhao. Rapid and accurate identification of COVID-19 infection through machine learning based on clinical available blood test results. medRxiv, 2020.